This Research Project Material is Based on
KNOWLEDGE AND ACCEPTABILITY OF CERVICAL CANCER SCREENING AMONG FEMALE PART-TIME STUDENTS IN UNIVERSITY OF BENIN
Cancer of the cervix remains the most common malignant neoplasm of the female genitalia and the second most common cancer in women.. Cervical Cancers screening serves to detect the possibility that a cancer is present. The main objective of the study was to determine the knowledge and acceptability of Cervicals Cancer Screening among Female Part- Time Students in University of Benin. The hypothesis for the study was: there is no relationship between knowledge of cervical cancer and acceptability of cervical cancer screening. Survey research design was used in the study. Simple random sampling was used to select the sample. The sample consisted of 200 Female Part- Time Students in University of Benin. Data was collected using questionnaire. The study findings revealed that slightly above half more than half of (74%) of the respondents were between the age of 20-25 years, 58 (77%) respondents could not remember age of their first sexual intercourse, the majority 168(86%) of respondents have heard of cervical cancer, majority 126 (63%) of respondents heard about cervical cancer from media, hundred and two (51%) participants explained cervical cancer as abnormal lesion on the cervix, sixty four (32%) respondents stated that unprotected sexual intercourse is a risk factor of cervicals cancer, sixty (30%) of respondents stated that abnormal vaginal bleeding is a sign of cervical cancer, 120 (60%) respondents stated that cervical cancer can be detected by cervicals cancer screening, majority 194 (97%) of respondents stated that cervical cancers screening is done in hospital, majority 178 (89%) of respondents had never been screened for cervical cancers, majority 94 (47%) of respondents strongly agreed that cervical cancer screening is important, the majority 144(72%) of the respondents had no intention of going for cervicals cancer screening, majority 80 (40%) of respondents stated that lack of awareness to cervical cancers screening is a major barrier to cervical cancer screening. The study recommends among others that nurses should engage more on giving Information Education and Communication (IEC) at all levels of Health Care Delivery toward cervical cancers screening. Cervical cancers screening center should be made available in university of Benin health center at subsidized amount so that female students can easily access the service.
BACKGROUND OF STUDY
Cervical cancer is the most common malignancies among females worldwide especially in women of 20–39 years of age. Its contribution to cancer burden is significant across all cultures and economies. Cervical cancer also accounts for over 270,000 deaths worldwide, an overwhelming majority of which occur in the less developed regions (Imam, 2008).
Globally there are over 500,000 new cases of cervical cancer annually and in excess of 270,000 deaths, accounting for 9% of female cancer deaths. 85% of cases occur in developing countries and in Africa (Campbell, 2008).
Cervical cancer remained the second leading cause of cancer deaths after breast cancer and the fifth most deadly cancer in women, accounting for approximately 10% of cancer deaths (Okonofua, 2007). The developing countries have carried a disproportionate share of the burden and 80 % of the 250,000 cervical cancer deaths in 2005 occurred there (WHO, 2007; Uysal & Birsel, 2009).
Cervical cancer is the malignant cancer of cervix uteri or cervical area. This happens when normal cells in the cervix change into cancer cells (Arbyn, 2005). Human Papilloma Virus (HPV) infection is a necessary factor in the development of nearly all cases of cervical cancer. Sexually transmitted human papilloma virus infection leads to the development of cervical intraepithelial neoplasia and cervical cancer (Colgan, 2006). HPV is spread through sexual contact and although most women’s bodies can fight the infection, sometimes the virus leads to the development of cervical cancer. HPV types 16 and 18 cause 70% of cervical cancer cases, whereas types 6 and 11 cause 90% of genital warts cases. During persistent HPV infection, precancerous changes may be detected in the cervix, that is, readily detectable changes occur in the cells lining the surface of the cervix, therefore early detection and treatment of these changes is an effective strategy for the prevention of cervical cancer and forms the basis of cervical screening programmes (Stephen, 2006).
Women with many sexual partners, and those whose partners have had many sexual consorts, or have been previously exposed to the virus, are most at risk of developing the disease (WHO, 2007). In developed countries of Europe and America that have organized national cervical screening programs, early detection and treatment of precancerous cervical lesions have resulted in a dramatic reduction in the incidence of and mortality from cervical cancer (WHO, 2007).
Pap smear screening can identify potentially precancerous changes. Treatment of high grade changes can prevent the development of cancer. Cervical cancer is a major risk in women today especially at the age of 20years and above. Awareness of screening programme, preventive vaccination and diet are preventive measures that reduce the incidence of cervical cancer. In developed countries, the widespread use of cervical screening programmes has reduced the incidence of invasive cervical cancer by 50% or more (Population Reference Bureau, 2005).
Cervical cancer is the most common genital tract malignancy of women living in poor rural communities of developing countries (Ferlay, 2006). Such populations lack cervical screening facilities and other basic infrastructural and human resources essential for effective primary healthcare delivery. Symptoms of cervical cancer include; vaginal discharge containing blood, abnormal vaginal bleeding, pelvic pain, blood in urine, bowel symptoms, blood in stool, painful sex, unusual vaginal bleeding, unusual vaginal discharge, contact bleeding, vaginal mass, moderate pain during sexual intercourse, loss of appetite, weight loss, fatigue. Others are loss of appetite, weight loss, fatigue, pelvic pain, back pain, leg pain, swollen leg, heavy bleeding from the vagina and leaking of urine or faeces from the vagina in advanced cases (Duncan, 2005).
Cervical cancer incidence and mortality rates have declined substantially in Western countries following the introduction of screening programmes. The ideal ages of women for screening are 30– 40 years owing to high risk of precancerous lesions due to being sexually active; and a precancerous lesion is detectable for 10 years or more before a cancer develops (Olamijulo, 2005). Although it has been already proven that the efficiency of regular pap tests reduced the mortality rate of cervical cancer, its application in the developing countries is less compared with the developed countries. The lack of knowledge concerning cervical cancer may be related to this fact (Yaren, 2008).
In developed countries, the widespread use of cervical screening programmes has reduced the incidence of invasive cervical cancer by 50% or more. Cervical cancer is one of the most preventable of all cancers through primary and secondary prevention, prophylactic Human Papilloma virus (HPV) vaccination and cervical screening (Ezem, 2006)
Cancer of the cervix remains the most common malignant neoplasm of the female genitalia and the second most common cancer in women (World Health Organization / Institute Catald’ Oncology – WHO/ICO, 2010). It’s the common cause of death among middle aged women, with an estimated 529,409 new cases and 274,883 deaths in 2008 (WHO/ICO,2010).The hardest – hit regions are countries such as Central and Southern America, the Caribbean, Sub Saharan Africa and part of the Oceania and Asia with the highest incidence over 30/100,000 women (Alliance of Cervical Cancer Prevention- ACCP,2005).
An estimated 1.4 million women worldwide are living with cervical cancer and 2 to 5 times more up to 7 million worldwide may have precancerous conditions that need to be identified and treated(ACCP,2005). In the United Kingdom (UK), cervical cancer is the second most common cancer among females under 35 years of age accounting for 702 new cases in 2007.According to the UK’ statistics report for 2010, 2,828 new cases were diagnosed in 2007.
Furthermore, WHO 2008 asserted that cervical cancer remains a major public health problem. The report further indicates that approximately 500 women develop cervical cancer and 274 deaths occur each year from cervical cancer in developing countries (WHO, 2008). More than 80% of the world’s new cases and deaths due to cervical cancer occur in the developing world and less than 5%women in these settings are never screened for cervical cancer even once in their life time (Sanghvi, Lacoste, McCormick, 2005).
Possible reasons for a low participation in cervical cancer screening include; ignorance of the existence of such test, ignorance of importance of screening or lack of risk awareness and the risk factors to the development of cervical cancer, absence of symptoms and lack of awareness of centers where such services are obtainable, and lack of motivation to get screened (Aniebue & Aniebue 2010)
STATEMENT OF THE PROBLEM
The level of awareness and utilization of cervical cytology services among women in the country is unclear as there is no reliable population – based cancer registry or prevention program databases, and very few regional – based studies have been reported in the country. (Gharoro & Ikeanyi, 2006).
Cancer prevention program in UBTH has recorded various degrees of successes, and limited to opportunistic screening until the establishment of Centre for Disease Control (CDC) in UBTH in 2006. What has been the norm is that women are screened when they attend for other gynaecological complaints during clinic visits and consultations. (Gharoro & Ikeanyi, 2006).
A search of literatures revealed that there are little evidence studies done on knowledge and acceptability of cervical cancer screening in the university of Benin community. One of such studies is the study carried out by Gharoro and Ikeanyi in 2006 on appraisal of the level of awareness and utilization of the pap smear as a cervical cancer screening test among female health workers in University of Benin Teaching Hospital. The study revealed that a large number of the female health workers were aware of the disease, cervical cancer and pap test availability in the hospital, yet, the screening uptake was abysmally poor.
Base on this gap in studies done on cervical cancer screening, the situation warrants a detailed study on the knowledge and acceptability of cervical cancer screening among Female Part- Time Students in University of Benin.
OBJECTIVES OF THE STUDY
- To determine the knowledge of cervical cancer screening among Female Part- Time Students in University of Benin.
- To determine the acceptability of cervical cancer screening among Female Part- Time Students in University of Benin.
- To identify barriers to cervical cancer screening service.
SIGNIFICANCE OF THE STUDY
Center for Disease Control (CDC) in University of Benin Teaching Hospital has recorded low utilization of cervical cancer screening service since the inception of the programme; therefore it is important that a study be conducted to determine the knowledge and acceptability of cervical cancer screening in its catchment area. For many years studies on cervical cancer related issues have focused on knowledge, attitude and practice towards cervical cancer. There are little evidence studies done on knowledge and acceptability of cervical cancer screening in University of Benin Community.
In view of this gap in studies done on cervical cancer, it is important that the researcher conducts a study to determine the knowledge and acceptability of cervical cancer screening among Female Part- Time Students in University of Benin. It is envisaged that the findings from this study will be used by the health care team to increase strategies on increasing knowledge and awareness on cervical cancer screening to women. Findings will also be used in planning and designing training manuals and guidelines and formulating deliberate policies in training nurses, doctors and other health personnel involved in the fight against cervical cancer. It has also been found appropriate to carry out this study because the results will be used to influence women’s behavior and practice towards cervical cancer screening in a positive way. Furthermore, the study results will form a basis for further research on cervical cancer screening.
- What is the level of cervical cancer awareness among the respondents?
- What is the level of acceptability of cervical cancer screening?
- What are the barriers to cervical cancer screening?
There is no relationship between knowledge of cervical cancer and acceptability of cervical cancer screening.
LIMITATIONS OF THE STUDY
1 The study was conducted within a short period of time which made it impossible for the researcher to conduct the research on a bigger scale.
2 There was limited published literature on knowledge of cervical cancer and cervical cancer screening in Nigeria, as a result much of the literature review was from other countries
SCOPE OF STUDY
Research setting is the physical location and conditions in which data collection takes place in the study, (Polit & Beck, 2008). The research setting can be seen as the physical, social, and cultural site in which the researcher conducts the study (Bhattacharya, 2008).The area of study is the University of Benin, Benin City, Edo state. University of Benin, Benin City, is geographically located at Ugbowo Community, in Ovia North East Local Government Area of Edo State. University of Benin is situated on 1,748 hectares of land along Benin – Lagos Highway. It shares a main boundary with University of Benin Teaching Hospital and Isiohor community. University was founded in the year 1970; her motto is “knowledge for service”. It is made up of 10 faculties namely; Agriculture Arts, Education, Engineering, Law, Life Science, Management Science, Pharmacy, Physical Science, Social science and School of Basic Sciences, College of Medicine and Dentistry.
CONCEPTUAL DEFINITIONS OF TERMS
Cervical cancer: Cervical cancer is a cancer of the cervix or neck of the uterus (Altaian & Sarg, 2006).
Screening: Screening is a test used to try and detect a disease when there is little or no evidence that a person has a disease (Berkow & Beer, 2007).
Pap smear: Pap smear is the cytological gynecologic test that examines the structure, function, pathology and chemistry of the cell (Black & Hawks, 2005)
Knowledge: Information, understanding, or skill that you get from experience or education. Awareness of something: the state of being aware of something (Merriam _ Webster Dictionary).
Acceptability: Acceptability is a state of welcoming something or acknowledging something (Geddes and Crosset, 2006).
OPERATIONAL DEFINITION TERMS
Knowledge:In this study knowledge means a woman who was able to define cervical cancer, state risk factors, signs and symptoms and mentioned services available for detection and prevention of cervical cancer.
Acceptability:In this study acceptability means a woman who was able to acknowledge the importance of screening for cervical cancer, had the intensions of going for cervical cancer screening and had accessed the screening service.
Cervical cancer:In this study, cervical cancer means a growth or a sore on the cervix or uterus.
OVERVIEW OF THE CERVICAL CANCER SCREENING
Cervical cancer is the third most common cancer in women, accounting for 9% of all female cancers. It is the seventh most common cancer in the world, and is more common in less developed countries-where it accounts for more than 85% of the global burden of cancer (Globocan, 2012). Cervical screening offers protective benefits and is associated with a reduction in the incidence of invasive cervical cancer and cervical cancer mortality (Peirson , 2013). The United States Preventive Services Task Force (USPSTF, 2012) and the American Cancer Society (ACS) recommend that all women should begin cervical cancer screening at age 21, every three years for women ages 21-65. Several other countries such as Barbados (Pan American Health Organization, 2013) and South Africa (Botha, 2010) also recommend to begin cervical cancer screen at the age of 21, while other countries such as Singapore, Jamaica, Colombia and Venezuela follow the recommendations of the World Health Organization (2013), namely to begin cervical cancer screening with the age of 25 years (Pan American Health Organization, 2013)
The WHO estimates that a one-time screening among women around the age of 40 could reduce the chance of fatality due to cervical cancer by 25-30% if adequately followed up. Since cervical cancer usually progresses slowly, this once-in-a-lifetime screening could prevent abnormal cells from becoming fatal (World Health Organization- Alliance of Cervical Cancer Prevention-WHO-ACCP, 2009).
Various studies among female university students in low and middle income countries have reported a low participation rate in screening for cervical cancer, e.g., 6% in Bhutan (Dhendup and Tshering, 2014), 12% in Ghana (aged 20 to 35 years) (Abotchie and Shokar, 2009), 6% in Malaysia (Al-Naggar, 2010), 0% to 8.3% in Nigeria (Ayinde, 2004; Akujobi, 2008; Oladepo, 2008; 2009; Aniebue and Aniebue, 2010), and 10.7% among sexually active female students in South Africa (Hoque, 2013). While studies among female university students in high income countries found a higher participation rate in screening for cervical cancer, e.g. 44.8% in Greece (Bakogianni, 2012) and 41% in USA (Durvasula, 2006)
FOR MORE RESEARCH PROJECT TOPICS AND MATERIALS, CLICK HERE